GB555293A - Improvements in or relating to iodine compounds and methods for producing the same - Google Patents

Improvements in or relating to iodine compounds and methods for producing the same

Info

Publication number
GB555293A
GB555293A GB691/42A GB69142A GB555293A GB 555293 A GB555293 A GB 555293A GB 691/42 A GB691/42 A GB 691/42A GB 69142 A GB69142 A GB 69142A GB 555293 A GB555293 A GB 555293A
Authority
GB
United Kingdom
Prior art keywords
iodine
solution
acidity
amino
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB691/42A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TYLER LAB Inc
Original Assignee
TYLER LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TYLER LAB Inc filed Critical TYLER LAB Inc
Priority to GB691/42A priority Critical patent/GB555293A/en
Publication of GB555293A publication Critical patent/GB555293A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

555,293. Iodine compounds. JACKSON, L. MELLERSH-. (Tyler Laboratories, Inc.). Jan. 16, 1942, No. 691. [Class 2 (iii)] [Also in Group VI] . An iodine compound of amino-acetic acid, the aqueous solution of which is a solvent for iodine, the solution being suitable for pharmaceutical and disinfectant purposes, is made by adding free iodine to an aqueous solution of amino-acetic acid, preferably in the presence of a small quantity of metallic iron. The ferric iodide produced from the iron may be removed by active carbon. For pharmaceutical purposes the acidity of the solution may be reduced by adding an alkaline salt such as an alkali bicarbonate, and potassium chloride, sodium chloride and sodium sulphate are preferably added. A strong alkali such as caustic soda should not be used to reduce the acidity when this is to be effected after iodine is dissolved in the solvent.
GB691/42A 1942-01-16 1942-01-16 Improvements in or relating to iodine compounds and methods for producing the same Expired GB555293A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB691/42A GB555293A (en) 1942-01-16 1942-01-16 Improvements in or relating to iodine compounds and methods for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB691/42A GB555293A (en) 1942-01-16 1942-01-16 Improvements in or relating to iodine compounds and methods for producing the same

Publications (1)

Publication Number Publication Date
GB555293A true GB555293A (en) 1943-08-16

Family

ID=9708829

Family Applications (1)

Application Number Title Priority Date Filing Date
GB691/42A Expired GB555293A (en) 1942-01-16 1942-01-16 Improvements in or relating to iodine compounds and methods for producing the same

Country Status (1)

Country Link
GB (1) GB555293A (en)

Similar Documents

Publication Publication Date Title
GB779389A (en) A stable solid diazonium compound and process for making it
GB602879A (en) Processes and compositions for the electrodeposition of indium alone or with other metals
GB555293A (en) Improvements in or relating to iodine compounds and methods for producing the same
GB1052028A (en)
SE308913B (en)
ES351689A1 (en) Improvements in or relating to Compositions Containing Choline Chloride
GB816592A (en) A method for the preparation of stable magnesium solutions of high concentration
GB613080A (en) Improvements in the preparation of stable medicinal salts of acetylsalicylic acid
GB553317A (en) Improvements in the production of alkaline earth metal pantothenates
GB547409A (en) Process for the preparation of 4-acetamido-2-hydroxyphenylarsenoxide
GB832105A (en) Improvements in or relating to cleansing and sterilising compositions
GB474518A (en) Improvements in or relating to cleansing agents
GB547027A (en) Improvements in or relating to the manufacture of bis-oxyphenyl compounds
GB558722A (en) A process for the manufacture of copper powder
GB657539A (en) Electrolytic oxidation of alcohols
GB572408A (en) Improvements in the production of compounds of arsenic
GB1001704A (en) Process for the production of water soluble derivatives of ªÐ-amino-salicylic acid
GB744379A (en) Stable, injectable solutions of 1-phenyl-2.3-dialkyl-4-dialkylamino-5-pyrazolones and process for their preparation
GB558469A (en) Improvements in or relating to the electrodeposition of copper
GB750916A (en) Process for the preparation of the dihydrostreptomycin salt of levulinic acid isonicotinylhydrazone
GB1173704A (en) Process for the Preparation of Naphthalene-1,4-Dicarboxylic Acid
GB858217A (en) Purification of magnesium salts
GB811882A (en) Baths for the electrolytic deposition of chromium
GB1274619A (en) Process for the preparation of straight-chain fatty acids
JPS5210206A (en) Process for preparation of pulenol